IPHA · Innate Pharma SA · Documents
Market Cap
$208.88M
Shares
111.70M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-09-10 | — | |
| 6-K | 2026-09-02 | — | |
| 6-K | 2026-08-19 | — | |
| 6-K | 2026-08-14 | — | |
| 6-K | 2026-08-10 | — | |
| 6-K | 2026-07-23 | — | |
| 6-K | 2026-07-21 | — | |
| 6-K | 2026-05-22 | — | |
| 6-K | 2026-05-19 | — | |
| 6-K | 2026-05-13 | — | |
| 6-K | 2026-05-12 | — | |
| 6-K | 2026-05-06 | — | |
| 6-K | 2026-04-23 | — | |
| 6-K | 2026-04-17 | — | |
| 6-K | 2026-04-13 | — | |
| 6-K | 2026-04-13 | — | |
| 6-K | 2026-04-08 | — | |
| 6-K | 2026-04-03 | — | |
| 6-K | 2026-04-02 | — | |
| 20-F | 2026-04-01 | 2025-12-31 | |
| 6-K | 2026-03-26 | — | |
| 6-K | 2026-03-19 | — | |
| 6-K | 2026-02-18 | — | |
| 6-K | 2026-01-07 | — | |
| 6-K | 2025-12-22 | — | |
| 6-K | 2025-12-11 | — | |
| 6-K | 2025-11-28 | — | |
| 6-K | 2025-11-17 | — | |
| 6-K | 2025-11-13 | — | |
| 6-K | 2025-11-10 | — | |
| 6-K | 2025-11-05 | — | |
| 6-K | 2025-10-15 | 2025-10-14 | |
| Investor Event Transcript | 2025-09-25 | 2025-09-30 | |
| 6-K | 2025-09-17 | 2025-06-30 | |
| 6-K | 2025-09-17 | 2025-06-30 | |
| 6-K | 2025-09-15 | — | |
| 6-K | 2025-09-10 | — | |
| 6-K | 2025-09-02 | — | |
| 6-K | 2025-08-04 | — | |
| 6-K | 2025-07-29 | — | |
| 6-K | 2025-07-07 | 2025-07-04 | |
| 6-K | 2025-06-17 | — | |
| 6-K | 2025-06-13 | — | |
| 6-K | 2025-05-27 | — | |
| 6-K | 2025-05-23 | — | |
| 6-K | 2025-05-23 | — | |
| 6-K | 2025-05-19 | — | |
| 6-K | 2025-05-15 | — | |
| 6-K | 2025-05-13 | — | |
| 6-K | 2025-05-12 | — |
Showing 1–50 of 278 filings